Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Cash (2021 - 2025)

Historic Change in Cash for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $8.4 million.

  • Biote's Change in Cash fell 2845.16% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.2 million, marking a year-over-year increase of 6278.98%. This contributed to the annual value of -$49.7 million for FY2024, which is 60823.87% down from last year.
  • As of Q3 2025, Biote's Change in Cash stood at $8.4 million, which was down 2845.16% from -$22.1 million recorded in Q2 2025.
  • In the past 5 years, Biote's Change in Cash registered a high of $55.0 million during Q2 2022, and its lowest value of -$52.4 million during Q2 2024.
  • Moreover, its 5-year median value for Change in Cash was $1.1 million (2024), whereas its average is $570526.3.
  • In the last 5 years, Biote's Change in Cash crashed by 189047.62% in 2022 and then surged by 122355.93% in 2023.
  • Quarter analysis of 5 years shows Biote's Change in Cash stood at $3.8 million in 2021, then crashed by 53.94% to $1.8 million in 2022, then skyrocketed by 1223.56% to $23.4 million in 2023, then crashed by 95.23% to $1.1 million in 2024, then surged by 656.22% to $8.4 million in 2025.
  • Its Change in Cash was $8.4 million in Q3 2025, compared to -$22.1 million in Q2 2025 and $2.4 million in Q1 2025.